STAT3 and hepatocellular carcinoma: Reduced STAT3 activation also was observed in liver sections from Stk25-/- mice with both DEN- and CDAA-induced HCC by immunohistochemistry analysis using anti–phospho-STAT3 antibody (Figure 7E).